Vaccines by Pfizer and BioNtech, as well as Moderna and AstraZeneca have shown promising results in large clinical trials, but there is no question of “cutting corners”, said Thomas Cueni, director-general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).
The Real Time News
More Stories
Saudi Arabia executed 25 people in 2020, the lowest number in years, rights groups say
Flight to detention: On the plane with Russia’s most wanted
One year, 4L Covid deaths: How the US guaranteed its own failure